86 related articles for article (PubMed ID: 8806810)
1. Native soluble CD5 delivers a costimulatory signal to resting human B lymphocytes.
Van de Velde H; Thielemans K
Cell Immunol; 1996 Aug; 172(1):84-91. PubMed ID: 8806810
[TBL] [Abstract][Full Text] [Related]
2. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity.
Cerutti A; Trentin L; Zambello R; Sancetta R; Milani A; Tassinari C; Adami F; Agostini C; Semenzato G
J Immunol; 1996 Sep; 157(5):1854-62. PubMed ID: 8757302
[TBL] [Abstract][Full Text] [Related]
3. Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72).
Luo W; Van de Velde H; von Hoegen I; Parnes JR; Thielemans K
J Immunol; 1992 Mar; 148(6):1630-4. PubMed ID: 1371783
[TBL] [Abstract][Full Text] [Related]
4. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.
Van de Velde H; von Hoegen I; Luo W; Parnes JR; Thielemans K
Nature; 1991 Jun; 351(6328):662-5. PubMed ID: 1711157
[TBL] [Abstract][Full Text] [Related]
5. CD72 ligation regulates defective naive newborn B cell responses.
Howard LM; Reen DJ
Cell Immunol; 1997 Feb; 175(2):179-88. PubMed ID: 9023424
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of B lymphocytes via CD72 (human Lyb-2).
Kamal M; Katira A; Gordon J
Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
[TBL] [Abstract][Full Text] [Related]
7. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
[TBL] [Abstract][Full Text] [Related]
8. Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals.
Clark EA; Shu GL; Lüscher B; Draves KE; Banchereau J; Ledbetter JA; Valentine MA
J Immunol; 1989 Dec; 143(12):3873-80. PubMed ID: 2480376
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
[TBL] [Abstract][Full Text] [Related]
10. Identity of human Lyb-2 and CD72 and localization of the gene to chromosome 9.
Von Hoegen I; Hsieh CL; Scharting R; Francke U; Parnes JR
Eur J Immunol; 1991 Jun; 21(6):1425-31. PubMed ID: 2044654
[TBL] [Abstract][Full Text] [Related]
11. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells.
Nagumo H; Agematsu K; Shinozaki K; Hokibara S; Ito S; Takamoto M; Nikaido T; Yasui K; Uehara Y; Yachie A; Komiyama A
J Immunol; 1998 Dec; 161(12):6496-502. PubMed ID: 9862673
[TBL] [Abstract][Full Text] [Related]
12. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
[TBL] [Abstract][Full Text] [Related]
14. Selective response of CD5+ B cell malignancies to activation of the CD72 antigen.
Planken EV; Van de Velde H; Falkenburg JH; Thielemans K; Willemze R; Kluin-Nelemans JC
Clin Immunol Immunopathol; 1998 Apr; 87(1):42-9. PubMed ID: 9576009
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation.
Blanchard DA; Affredou MT; Vazquez A
J Immunol; 1997 Apr; 158(7):3054-61. PubMed ID: 9120257
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibodies specific for equine homologues of CD3 and CD5.
Blanchard-Channell M; Moore PF; Stott JL
Immunology; 1994 Aug; 82(4):548-54. PubMed ID: 7530685
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cell morphology in B lymphocytes by IL-4: evidence for induced cytoskeletal changes.
Davey EJ; Thyberg J; Conrad DH; Severinson E
J Immunol; 1998 Jun; 160(11):5366-73. PubMed ID: 9605136
[TBL] [Abstract][Full Text] [Related]
18. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.
Agrewala JN; Suvas S; Verma RK; Mishra GC
J Immunol; 1998 Feb; 160(3):1067-77. PubMed ID: 9570518
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation defines a unique transduction pathway in human B cells mediated via CD40.
Faris M; Gaskin F; Geha RS; Fu SM
Trans Assoc Am Physicians; 1993; 106():187-95. PubMed ID: 7518623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
